Optimal Teicoplanin Dosing Regimen in Neonates and Children Developed by Leveraging Real-World Clinical Information.

Yamada, Takaaki; Emoto, Chie; Fukuda, Tsuyoshi; Motomura, Yoshitomo; Inoue, Hirosuke; Ohga, Shouichi; Ieiri, Ichiro

Yamada, Takaaki; Emoto, Chie; Fukuda, Tsuyoshi; Motomura, Yoshitomo; Inoue, Hirosuke; Ohga, Shouichi; Ieiri, Ichiro.

Afiliação

Yamada T; Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan.
Emoto C; Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University.
Fukuda T; Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University.
Motomura Y; National Center for Child Health and Development, Tokyo, Japan; and.
Inoue H; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ohga S; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ieiri I; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Ther Drug Monit ; 44(3): 404-413, 2022 06 01.

Article em En | MEDLINE | ID: mdl-34629445

Assuntos

Staphylococcus aureus Resistente à Meticilina; Teicoplanina; Antibacterianos/farmacocinética; Criança; Monitoramento de Medicamentos; Humanos; Recém-Nascido; Método de Monte Carlo; Teicoplanina/farmacocinética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Teicoplanina / Staphylococcus aureus Resistente à Meticilina Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Child / Humans / Newborn Idioma: En Revista: Ther Drug Monit Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google